120 related articles for article (PubMed ID: 32738753)
1. New core configuration for the fabrication of
Daruich de Souza C; Alberto Zeituni C; Feher A; Augusto Moura J; Luiz da Costa O; Angelocci LV; Rostelato MECM
Appl Radiat Isot; 2020 Nov; 165():109307. PubMed ID: 32738753
[TBL] [Abstract][Full Text] [Related]
2. Monte Carlo calculated TG-43 dosimetry parameters for the SeedLink 125Iodine brachytherapy system.
Medich DC; Munro JJ
Med Phys; 2003 Sep; 30(9):2503-8. PubMed ID: 14528972
[TBL] [Abstract][Full Text] [Related]
3. Dose perturbation effects in prostate seed implant brachytherapy with I-125.
Mobit P; Badragan I
Phys Med Biol; 2004 Jul; 49(14):3171-8. PubMed ID: 15357190
[TBL] [Abstract][Full Text] [Related]
4. Monte Carlo investigation of I-125 interseed attenuation for standard and thinner seeds in prostate brachytherapy with phantom validation using a MOSFET.
Mason J; Al-Qaisieh B; Bownes P; Henry A; Thwaites D
Med Phys; 2013 Mar; 40(3):031717. PubMed ID: 23464312
[TBL] [Abstract][Full Text] [Related]
5. Dosimetric parameters for three low-energy brachytherapy sources using the Monte Carlo N-particle code.
DeMarco JJ; Hugo G; Solberg TD
Med Phys; 2002 May; 29(5):662-8. PubMed ID: 12033560
[TBL] [Abstract][Full Text] [Related]
6. CT-based dosimetry calculations for 125I prostate implants.
DeMarco JJ; Smathers JB; Burnison CM; Ncube QK; Solberg TD
Int J Radiat Oncol Biol Phys; 1999 Dec; 45(5):1347-53. PubMed ID: 10613332
[TBL] [Abstract][Full Text] [Related]
7. Sensitivity of low energy brachytherapy Monte Carlo dose calculations to uncertainties in human tissue composition.
Landry G; Reniers B; Murrer L; Lutgens L; Gurp EB; Pignol JP; Keller B; Beaulieu L; Verhaegen F
Med Phys; 2010 Oct; 37(10):5188-98. PubMed ID: 21089752
[TBL] [Abstract][Full Text] [Related]
8. Brachytherapy dosimetry of 125I and 103Pd sources using an updated cross section library for the MCNP Monte Carlo transport code.
Bohm TD; DeLuca PM; DeWerd LA
Med Phys; 2003 Apr; 30(4):701-11. PubMed ID: 12722822
[TBL] [Abstract][Full Text] [Related]
9. A Monte Carlo study of I-125 prostate brachytherapy with gold nanoparticles: dose enhancement with simultaneous rectal dose sparing via radiation shielding.
Brivio D; Nguyen PL; Sajo E; Ngwa W; Zygmanski P
Phys Med Biol; 2017 Mar; 62(5):1935-1948. PubMed ID: 28140338
[TBL] [Abstract][Full Text] [Related]
10. Improved radial dose function estimation using current version MCNP Monte-Carlo simulation: Model 6711 and ISC3500 125I brachytherapy sources.
Duggan DM
Appl Radiat Isot; 2004 Dec; 61(6):1443-50. PubMed ID: 15388146
[TBL] [Abstract][Full Text] [Related]
11. [The treatment of localized cancer of the prostate using radioactive iodine implants].
Fradet Y; Laverdière J; Beaudoin L
Union Med Can; 1985 Sep; 114(9):737-9. PubMed ID: 4060345
[No Abstract] [Full Text] [Related]
12. Radioactive seed migration after prostate brachytherapy with iodine-125 using loose seeds versus stranded seeds.
Franca CA; Vieira SL; Carvalho AC; Bernabe AJ; Penna AB
Int Braz J Urol; 2009; 35(5):573-9; discussion 579-80. PubMed ID: 19860936
[TBL] [Abstract][Full Text] [Related]
13. Investigation of interseed attenuation and tissue composition effects in (125)I seed implant prostate brachytherapy.
Mason J; Al-Qaisieh B; Bownes P; Henry A; Thwaites D
Brachytherapy; 2014; 13(6):603-10. PubMed ID: 24913435
[TBL] [Abstract][Full Text] [Related]
14. Relative biological effectiveness enhancement of a 125I brachytherapy seed with characteristic x rays from its constitutive materials.
Taschereau R; Roy R; Pouliot J
Med Phys; 2002 Jul; 29(7):1397-402. PubMed ID: 12148718
[TBL] [Abstract][Full Text] [Related]
15. Is a loose-seed nomogram still valid for prostate brachytherapy in a stranded-seed era?
Kudchadker RJ; Swanson DA; Kuban DA; Lee AK; Bruno TL; Frank SJ
Int J Radiat Oncol Biol Phys; 2008 Oct; 72(2):623-7. PubMed ID: 18410998
[TBL] [Abstract][Full Text] [Related]
16. Experimental measurements and Monte Carlo simulations of dose perturbation around a nonradioactive brachytherapy seed due to 6- and 18-MV photons.
Steinman JP; Bakhtiari M; Malhotra HK
Brachytherapy; 2012; 11(5):413-20. PubMed ID: 21737357
[TBL] [Abstract][Full Text] [Related]
17. Experimental determination of the TG-43 dosimetric characteristics of EchoSeed model 6733 I25I brachytherapy source.
Meigooni AS; Dini SA; Sowards K; Hayes JL; Al-Otoom A
Med Phys; 2002 Jun; 29(6):939-42. PubMed ID: 12094988
[TBL] [Abstract][Full Text] [Related]
18. A calculation of the relative biological effectiveness of 125I and 103Pd brachytherapy sources using the concept of proximity function.
Wuu CS; Zaider M
Med Phys; 1998 Nov; 25(11):2186-9. PubMed ID: 9829243
[TBL] [Abstract][Full Text] [Related]
19. A modern Monte Carlo investigation of the TG-43 dosimetry parameters for an 125I seed already having AAPM consensus data.
Aryal P; Molloy JA; Rivard MJ
Med Phys; 2014 Feb; 41(2):021702. PubMed ID: 24506593
[TBL] [Abstract][Full Text] [Related]
20. The investigation of prostatic calcifications using μ-PIXE analysis and their dosimetric effect in low dose rate brachytherapy treatments using Geant4.
Pope DJ; Cutajar DL; George SP; Guatelli S; Bucci JA; Enari KE; Miller S; Siegele R; Rosenfeld AB
Phys Med Biol; 2015 Jun; 60(11):4335-53. PubMed ID: 25984817
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
